Abstract
375 SYNTHESIS, CHARACTERIZATION, DOCKING, ANTICANCER AND ANTIMICROBIAL STUDIES OF NOVEL SCHIFF BASE LIGAND DERIVED FROM SALICYLALDEHYDE AND ITS NICKEL (II) COMPLEX

A. P. Arumugam, G. Elango and S. Guhanathan*

ABSTRACT

A new series of Co(II), Ni(II), Cu(II) and Zn(II) complexes of the Schiff base derived from Vanillin and acetoacetanilide with ethylenediamine has been synthesized. A new series of Ni(II) complex of the Schiff base derived from salicylaldehyde and 3,4-diaminobenzophenone with acetyl acetone have been synthesized. These compound have been characterized by molar conductivity measurements, infrared, electronic spectra. The Schiff base ligand and its complex further identified by 1H NMR, 13C NMR and molecular docking study. The anticancer potential of the Nickel (II) complex was determined against A549 lung cancer cells, they exhibited appreciable anticancer activity. The in vitro cytotoxicity of the complex was examined against cancer cell line by MTT assay. The Schiff base Ni(II) complex was tested its cytotoxicity and found that the 50 percentage of activity inhibitory concentration (IC50) value around 40.47 percentage in 1000 μg/ml. Antimicrobial activity of the Schiff base ligand and their metal complex reveals that the Schiff base transition metal complex show significant activity against some bacteria. model and EAC cell induced ascites tumour model were mainly used for antitumor studies. Copper complex administrated at different concentrations in Swiss albino mice to access increases in the survival rate and the life span of Ascites tumour enduring mice in a concentration dependent manner. Antimicrobial activities of the Schiff base ligand and their metal complexes reveals that the Schiff base transition metal complexes show significant activity against some fungi and bacteria.

Keywords: Docking study, anticancer activity and antimicrobial activity.


[Full Text Article]   [Download Certificate]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: APRIL ISSUE PUBLISHED

    APRIL 2024 Issue has been successfully launched on 1 APRIL 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT